CFM
ZURA icon

Catalyst Funds Management’s Zura Bio ZURA Stock Holding History

Catalyst Funds Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,300
Closed -$91K – 919
2026
Q1 		$91K Buy
+15,300
New +$92.4K 0.02% 495
2025
Q3 		– Sell
-23,300
Closed -$24.5K – 677
2025
Q2 		$24.5K Buy
+23,300
New +$27.9K 0.01% 418

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Catalyst Funds Management's ZURA Position: Q2 2026 in Review

Catalyst Funds Management sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 15,300 shares — an estimated $91K sold.

Catalyst Funds Management first reported a position in ZURA in Q2 2025 and held it in 2 quarters. The position peaked at $91K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Catalyst Funds Management reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 15,300 Zura Bio shares in Q2 2026, an estimated $91K.
  • Catalyst Funds Management first reported a position in Zura Bio in Q2 2025 and held it in 2 quarters.
  • Catalyst Funds Management's Zura Bio position peaked at $91K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.